Literature DB >> 15618039

Functional impact of rate irregularity in patients with heart failure and atrial fibrillation receiving cardiac resynchronization therapy.

Vojtech Melenovsky1, Ilan Hay, Barry J Fetics, Barry A Borlaug, Andrew Kramer, Joseph M Pastore, Ronald Berger, David A Kass.   

Abstract

AIMS: Atrial fibrillation (AFib) with a rapid ventricular response may adversely impact cardiac performance, especially in patients with heart failure. However, it remains uncertain whether rhythm irregularity per se has unfavourable effects apart from tachycardia, and whether rate regularization alone can improve heart function. METHODS AND
RESULTS: Nine subjects with chronic AFib, atrioventricular nodal block, and symptomatic heart failure (ejection fraction 14-30%) were studied using a pressure-volume catheter. Ventricles were biventricularly paced (RV-apex, LV-lateral wall) at 80 or 120 min(-1) mean rate, using regular or irregular, Poisson-distributed stimulation. At 80 min(-1), ventricular function was similar between the two pacing modes. However, at 120 min(-1), irregular pacing impaired systolic (dP/dt(max): -8.2%, P<0.001) and diastolic function (dP/dt(min): +21%, P<0.001, LV end-diastolic pressure: +26%, P=0.007) compared with regular rate pacing. Contractile function during irregular pacing varied with the ratio of preceding/pre-preceding intercycle (RR) interval (dP/dt(max): 80 b.p.m.: r=0.69; 120 b.p.m.: r=0.74), whereas pre-load had little effect on instantaneous contractility.
CONCLUSION: In heart failure subjects with AFib, RR-interval irregularity worsens cardiac function at elevated but not at normal range heart rate. Overall rate control is most important in these patients while rate regularization of rapid AFib may impart additional benefits.

Entities:  

Mesh:

Year:  2004        PMID: 15618039     DOI: 10.1093/eurheartj/ehi066

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

1.  [Optimized CRT programming: relevance and practical application].

Authors:  F Bode; F Schütte
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-09

2.  Catheter ablation of atrial fibrillation and outcomes in heart failure patients: seeking the treasure in the CASTLE.

Authors:  Stanley Nattel
Journal:  Cardiovasc Res       Date:  2018-06-01       Impact factor: 10.787

Review 3.  Cardiac Resynchronization Therapy and Atrial Fibrillation.

Authors:  Ganesh S Kamath; Jonathan S Steinberg
Journal:  J Atr Fibrillation       Date:  2011-09-30

Review 4.  Cardiac Resynchronization Therapy in Patients with Atrial Fibrillation - Worth the Effort?

Authors:  António M Ferreira; Pedro Carmo; Pedro Adragão
Journal:  J Atr Fibrillation       Date:  2012-04-14

Review 5.  [Effect of cardiac resynchronization therapy (CRT) on exercise tolerance, functional capacity and quality of life in patients with congestive heart failure].

Authors:  C Butter
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2005-03

Review 6.  Resynchronization therapy in the context of atrial fibrillation: benefits and limitations.

Authors:  Uta C Hoppe
Journal:  J Interv Card Electrophysiol       Date:  2007-04-21       Impact factor: 1.900

7.  Short-term ECG recordings for heart rate assessment in patients with chronic atrial fibrillation.

Authors:  Michal Chudzik; Iwona Cygankiewicz; Artur Klimczak; Joanna Lewek; Karol Bartczak; Jerzy K Wranicz
Journal:  Arch Med Sci       Date:  2014-08-29       Impact factor: 3.318

8.  Feasibility of In-Vivo Simulation of Acute Hemodynamics in Human Atrial Fibrillation.

Authors:  Marek Sramko; Dan Wichterle; Josef Kautzner
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

9.  Variability in interbeat duration influences myocardial contractility in rat cardiac trabeculae.

Authors:  Carlos A A Torres; Kenneth D Varian; Paul M L Janssen
Journal:  Open Cardiovasc Med J       Date:  2008-11-21

10.  Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation.

Authors:  Maurizio Gasparini; Angelo Auricchio; Marco Metra; François Regoli; Cecilia Fantoni; Barbara Lamp; Antonio Curnis; Juergen Vogt; Catherine Klersy
Journal:  Eur Heart J       Date:  2008-04-04       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.